Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
66.85
+6.11 (10.06%)
At close: Sep 25, 2026, 4:00 PM EDT
67.14
+0.29 (0.43%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $218.87 million as of September 25, 2026. Its market cap has increased by 182.77% in one year.
Market Cap
218.87M
Enterprise Value
171.71M
1-Year Change
182.77%
Ranking
Category
Stock Price
$66.85
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $228.30M to $218.87M, a decrease of -4.13%. That is a compound annual growth rate of -0.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 218.90M | 86.46% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 230.39M |
| Cue Biopharma | 228.18M |
| Compugen | 225.44M |
| Cartesian Therapeutics | 224.19M |
| Entrada Therapeutics | 222.11M |
| Anavex Life Sciences | 220.62M |
| Protalix BioTherapeutics | 219.15M |
| Alector | 217.73M |